Literature DB >> 32767267

The Natural Course of Impaired Fasting Glucose.

Agnieszka Święcicka-Klama1,2, Katarzyna Połtyn-Zaradna3, Andrzej Szuba4, Katarzyna Zatońska3.   

Abstract

Impaired glucose regulation, including diabetes and prediabetes, poses a huge global problem not only in health but also in the epidemiological and economic areas. These disorders are often detected too late or remain unrecognized. The article aims to provide a review of the prevalence, etiology, and natural history of impaired fasting glucose (IFG). We focus on the progression of isolated IFG to full-fledged type 2 diabetes and the factors conducive to the development of diabetes. The knowledge about it could help design an optimal management program for the prevention of diabetes in patients with IFG; a program that would be patient-tailored and based on the underlying pathophysiology.

Entities:  

Keywords:  Diabetes; Impaired fasting glucose; Prediabetes; Prevention; Public health

Mesh:

Substances:

Year:  2021        PMID: 32767267     DOI: 10.1007/5584_2020_571

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  58 in total

1.  Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.

Authors:  Muhammad A Abdul-Ghani; Christopher P Jenkinson; Dawn K Richardson; Devjit Tripathy; Ralph A DeFronzo
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

Review 2.  Definitions (and Current Controversies) of Diabetes and Prediabetes.

Authors:  Martin Buysschaert; Jose-Luis Medina; Benoit Buysschaert; Michael Bergman
Journal:  Curr Diabetes Rev       Date:  2016

3.  Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.

Authors:  Rita Basu; Cristina Barosa; John Jones; Simmi Dube; Rickey Carter; Ananda Basu; Robert A Rizza
Journal:  J Clin Endocrinol Metab       Date:  2013-01-23       Impact factor: 5.958

4.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

Review 5.  Novel Risk Factors for Type 2 Diabetes in African-Americans.

Authors:  Ranee Chatterjee; Nisa M Maruthur; David Edelman
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

6.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

7.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Authors:  Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

8.  Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance.

Authors:  Hilary Chatterton; Tricia Younger; Alastair Fischer; Kamlesh Khunti
Journal:  BMJ       Date:  2012-07-12

9.  Implications of rising prediabetes prevalence.

Authors:  Tobin M Abraham; Caroline S Fox
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

10.  Secular changes in U.S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010.

Authors:  Kai McKeever Bullard; Sharon H Saydah; Giuseppina Imperatore; Catherine C Cowie; Edward W Gregg; Linda S Geiss; Yiling J Cheng; Deborah B Rolka; Desmond E Williams; Carl J Caspersen
Journal:  Diabetes Care       Date:  2013-04-19       Impact factor: 19.112

View more
  2 in total

1.  TG: HDL-C Ratio as Insulin Resistance Marker for Metabolic Syndrome in Children With Obesity.

Authors:  Ahmad Kamil Nur Zati Iwani; Muhammad Yazid Jalaludin; Abqariyah Yahya; Fazliana Mansor; Fuziah Md Zain; Janet Yeow Hua Hong; Ruziana Mona Wan Mohd Zin; Abdul Halim Mokhtar
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-10       Impact factor: 5.555

Review 2.  Can Newer Anti-Diabetic Therapies Delay the Development of Diabetic Nephropathy?

Authors:  Sohail Aziz; Siti Maisharah Sheikh Ghadzi; Syed Azhar Syed Sulaiman; Nur Hafzan Md Hanafiah; Sabariah Noor Harun
Journal:  J Pharm Bioallied Sci       Date:  2022-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.